Autonomic Control of the Circulation and VDR
Milton S. Hershey Medical Center · with National Heart, Lung, and Blood Institute (NHLBI) · NCT03513770
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 18
- US sites recruiting
- 1
- Study start
- August 14, 2019
- Record last updated
- July 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.
Being studied: Wrist-to-elbow (W-E) occlusion; ketorolac tromethamine; saline control
Conditions: Venous Distension Reflex; Blood Pressure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Are capable of giving informed consent
- Are any race or ethnicity
- Are fluent in written and spoken English
- Have a satisfactory history and physical exam to meet inclusion/exclusion criteria
- Are free of acute or chronic medical conditions
- Are 21 - 35 years of age (inclusive)
- Weigh over 50 kg
Exclusion Criteria
- Are less than 21 or over 35 years of age
- Are Pregnant or nursing women
- Are prisoners or institutionalized individuals or unable to consent
- Any chronic diseases (hypertension, heart, lung, neuromuscular disease, kidney disease, diabetes or cancer).
- Are taking medications that may affect their cardiovascular or nervous system
- Has taken an NSAID within 48 hours of any visit (visit will need to be rescheduled)
- Has never taken NSAIDs and therefore would not know if they are allergic to it
- Have a supine BP >140/90 mmHg
- Have known allergy to ibuprofen-like drugs (NSAIDS) or aspirin
- Have history of asthma or nasal polyps
- Have history of GI bleeding or ulcers
- Subjects with ferromagnetic metal implants
- Subjects who are claustrophobic
Recruiting US locations
Penn State Milton S. Hershey Medical Center
Hershey, PA 17033
Site contact: Jian Cui · 7175311799 · jcui@pennstatehealth.psu.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only